NCT06835699View on ClinicalTrials.gov

Psilocybin Brain Stimulation and Imaging Pilot Study

PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 18, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Healthy Volunteers
Interventions
DRUG

Psilocybin 25 mgs

All participants will be administered 25 mg psilocybin and undergo TMS

DEVICE

TMS

All participants will be administered 25 mg psilocybin and undergo TMS

Trial Locations (1)

21214

RECRUITING

Johns Hopkins School of Medicine, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER